Longitude Capital Expands Biotechnology Practice With Matthew Young, Former Grail COO and Jazz EVP, and Cadre of New Talent by Seini Moimoi | Nov 17, 2022 | Longitude Capital News
CG Oncology Raises $120 Million in Oversubscribed Series E Financing to Advance Clinical-Stage Urologic Oncology Pipeline by Seini Moimoi | Nov 15, 2022 | Portfolio News
Talaris Therapeutics Announces Third Quarter Financial Results and Corporate Update by Seini Moimoi | Nov 10, 2022 | Portfolio News
Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results by Seini Moimoi | Nov 10, 2022 | Portfolio News
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2022 by Seini Moimoi | Nov 10, 2022 | Portfolio News
Nabriva Therapeutics Pivoting Strategic Focus Reports Third Quarter Financial Results and Provides Corporate Update by Seini Moimoi | Nov 10, 2022 | Portfolio News
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results by Seini Moimoi | Nov 10, 2022 | Portfolio News
Inozyme Pharma Reports Third Quarter 2022 Financial Results and Provides Business Updates by Seini Moimoi | Nov 10, 2022 | Portfolio News
89bio Reports Third Quarter 2022 Financial Results and Provides Corporate Update by Seini Moimoi | Nov 10, 2022 | Portfolio News
Vera Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results by Seini Moimoi | Nov 9, 2022 | Portfolio News
